CWC Advisors LLC. Buys 1,092 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

CWC Advisors LLC. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 57.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,977 shares of the healthcare conglomerate's stock after buying an additional 1,092 shares during the quarter. CWC Advisors LLC.'s holdings in UnitedHealth Group were worth $1,559,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of UNH. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the 4th quarter worth about $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth about $32,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Up 2.1%

Shares of NYSE UNH traded up $6.23 during mid-day trading on Friday, reaching $308.85. 13,584,804 shares of the company traded hands, compared to its average volume of 7,465,895. The stock has a market cap of $280.17 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44. The company's fifty day moving average is $336.21 and its two-hundred day moving average is $454.51. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period last year, the business earned $6.91 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. TD Securities reissued a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. HSBC reaffirmed a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Finally, UBS Group cut their price target on UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating for the company in a research note on Wednesday. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $415.57.

Insider Buying and Selling at UnitedHealth Group

In other news, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares of the company's stock, valued at $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer now owns 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.28% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.